{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:43:27Z","timestamp":1791438207164,"version":"4.3.3"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.diabet.2024.101524","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T20:19:35Z","timestamp":1707596375000},"page":"101524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study"],"prefix":"10.1016","volume":"50","author":[{"given":"Fadi","family":"Alkhami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Borderie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninon","family":"Foussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Larroumet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Am\u00e9lie","family":"Barbet-Massin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Ferriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Ducos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Fawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Couffinhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-6479","authenticated-orcid":false,"given":"Vincent","family":"Rigalleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2024.101524_bib0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101524_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.08.002","article-title":"Risk stratification and screening for coronary heart disease in asymptomatic patients with diabetes mellitus: position paper of the French Society of Cardiology and the French-speaking Society of Diabetology","volume":"47","author":"Valensi","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101524_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2009.06.005","article-title":"Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies","volume":"36","author":"Daroux","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101524_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007397","article-title":"Circulating Concentrations of redox biomarkers do not improve the prediction of adverse cardiovascular events in patients with type 2 diabetes mellitus","volume":"7","author":"Cournot","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabet.2024.101524_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.diabet.2014.12.001","article-title":"Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease","volume":"4","author":"-Hofmann","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101524_bib0006","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/dia.2006.8.523","article-title":"Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation end products: an overview of current clinical studies, evidence, and limitations","volume":"8","author":"Mulder","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2024.101524_bib0007","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101524_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108015","article-title":"Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: a prospective cohort study from the Hong Kong Diabetes Biobank","volume":"35","author":"Jin","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabet.2024.101524_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-020-00676-4","article-title":"Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes","volume":"21","author":"Boersma","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabet.2024.101524_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100038","article-title":"Skin autofluorescence, a marker of glucose memory in type 2 diabetes","volume":"7","author":"Rigo","year":"2020","journal-title":"Metabol Open"},{"key":"10.1016\/j.diabet.2024.101524_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12933-021-01409-0","article-title":"Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes","volume":"20","author":"-Sharif","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101524_bib0012","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2024.101524_bib0013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2015.03.040","article-title":"High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events","volume":"240","author":"-Stoekenbroek","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabet.2024.101524_bib0014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/diacare.27.1.201","article-title":"Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66","volume":"27","author":"Stevens","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101524_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcn\/nqaa117","article-title":"The association between dietary and skin advanced glycation end products: the Rotterdam Study","volume":"112","author":"Chen","year":"2020","journal-title":"Am J Clin Nutr"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:59:31Z","timestamp":1761130771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363624000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1262363624000168"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101524","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101524"}}